{"id":"saline-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Eye irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They do this by creating a protective film on the surface of the eye, which helps to reduce friction and discomfort. This can be especially helpful for people who experience dry eye syndrome or have undergone eye surgery.","oneSentence":"Saline eye drops work by lubricating the eyes to help relieve dryness and irritation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:33:23.220Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome"},{"name":"Eye irritation"}]},"trialDetails":[{"nctId":"NCT07151612","phase":"PHASE4","title":"The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Shanxi Eye Hospital","startDate":"2025-09-04","conditions":"Presbyopia","enrollment":62},{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT04838223","phase":"","title":"Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)","status":"SUSPENDED","sponsor":"Tufts Medical Center","startDate":"2021-07-02","conditions":"Dry Eye, Neuropathic Pain","enrollment":1000},{"nctId":"NCT06271772","phase":"PHASE3","title":"Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Bacterial Keratitis","enrollment":60},{"nctId":"NCT04007276","phase":"PHASE4","title":"The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Tulane University","startDate":"2026-11-10","conditions":"Glaucoma, Glaucoma, Open-Angle, Glaucoma; Drugs","enrollment":60},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT07154147","phase":"PHASE4","title":"Oral vs IV Sedation for Cataract Surgery in Older Adults","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-08-12","conditions":"Cataract Surgery, Sedation, Cognition Function","enrollment":20},{"nctId":"NCT06329661","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine","status":"COMPLETED","sponsor":"Novaliq GmbH","startDate":"2024-04-22","conditions":"Dry Eye Disease","enrollment":204},{"nctId":"NCT07124143","phase":"NA","title":"The Effect of Platelet-Rich Plasma on Wound Healing After Gingivectomy","status":"COMPLETED","sponsor":"Duygu Kilic","startDate":"2021-06-02","conditions":"Gingival Overgrowth","enrollment":38},{"nctId":"NCT06352541","phase":"PHASE1","title":"Study Evaluating PRO-232 an Ophthalmic Solution Compared to Placebo.","status":"NOT_YET_RECRUITING","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-09-30","conditions":"Healthy","enrollment":28},{"nctId":"NCT07050446","phase":"PHASE3","title":"Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye","status":"COMPLETED","sponsor":"Jadran Galenski laboratorij d.d.","startDate":"2024-03-20","conditions":"Dry Eye Disease (DED)","enrollment":86},{"nctId":"NCT03911271","phase":"PHASE2","title":"Low-dose Atropine for the Prevention of Myopia Progression in Danish Children","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2019-05-30","conditions":"Myopia","enrollment":97},{"nctId":"NCT06655441","phase":"PHASE4","title":"The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2025-09-01","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT07000565","phase":"NA","title":"The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-11-01","conditions":"Ocular Surface Disease","enrollment":42},{"nctId":"NCT06242379","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-23","conditions":"Retinitis Pigmentosa","enrollment":15},{"nctId":"NCT03733899","phase":"NA","title":"An Investigation of the Impact of Localized Topical Anesthesia of the Ocular Surface on End-of-day Contact Lens Discomfort","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2018-11-07","conditions":"Visual Acuity","enrollment":22},{"nctId":"NCT03298815","phase":"PHASE1, PHASE2","title":"Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)","status":"COMPLETED","sponsor":"University of Utah","startDate":"2019-12-20","conditions":"Ocular Graft Versus Host Disease","enrollment":15},{"nctId":"NCT03865160","phase":"PHASE2, PHASE3","title":"Low-dose Atropine for Myopia Control in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Eye Hospital, Freiburg","startDate":"2021-10-19","conditions":"Myopia, Progressive","enrollment":302},{"nctId":"NCT06851364","phase":"PHASE2","title":"Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants","status":"COMPLETED","sponsor":"International Islamic University Malaysia","startDate":"2022-10-30","conditions":"Dry Eye","enrollment":45},{"nctId":"NCT02510235","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-03-09","conditions":"Dry Eye Syndrome, Tear Film Insufficiency","enrollment":56},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT02707120","phase":"PHASE4","title":"Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis","status":"WITHDRAWN","sponsor":"Biotechnology Institute IMASD","startDate":"2018-01-04","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT05666362","phase":"PHASE4","title":"Hemodynamic Response to Pain During Retinopathy Of Prematurity Screening","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-01-20","conditions":"Preterm","enrollment":68},{"nctId":"NCT06048380","phase":"PHASE3","title":"The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery","status":"RECRUITING","sponsor":"Singapore Eye Research Institute","startDate":"2025-03-01","conditions":"Fuchs' Endothelial Dystrophy, Cataract","enrollment":120},{"nctId":"NCT06565650","phase":"PHASE4","title":"A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bausch & Lomb Incorporated","startDate":"2024-07-31","conditions":"Dry Eye","enrollment":216},{"nctId":"NCT06673784","phase":"","title":"Evaluation and Risk Factors of Post-traumatic Endophthalmitis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-11-10","conditions":"Endophthalmitis","enrollment":41},{"nctId":"NCT02507934","phase":"NA","title":"Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye","status":"COMPLETED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2015-06-26","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT06533995","phase":"NA","title":"The Usefulness of Visuprime in Cataract Surgery","status":"COMPLETED","sponsor":"VISUfarma SpA","startDate":"2021-10-25","conditions":"Cataract","enrollment":75},{"nctId":"NCT04192994","phase":"NA","title":"Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2019-01-01","conditions":"Endophthalmitis","enrollment":25},{"nctId":"NCT04281004","phase":"PHASE1, PHASE2","title":"Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-07-10","conditions":"Photorefractive Keratectomy","enrollment":61},{"nctId":"NCT06365762","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract","status":"COMPLETED","sponsor":"Livionex Inc.","startDate":"2006-01-01","conditions":"Age Related Cataracts","enrollment":111},{"nctId":"NCT06323395","phase":"PHASE3","title":"Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry Eye","status":"COMPLETED","sponsor":"Jadran Galenski laboratorij d.d.","startDate":"2022-06-01","conditions":"Dry Eye Disease","enrollment":64},{"nctId":"NCT06317922","phase":"NA","title":"Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections","status":"RECRUITING","sponsor":"Francesco Bandello","startDate":"2024-02-05","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT05390840","phase":"PHASE2","title":"A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD)","status":"UNKNOWN","sponsor":"Theratocular Biotek Co.","startDate":"2022-08-09","conditions":"Age-Related Macular Degeneration","enrollment":36},{"nctId":"NCT06294015","phase":"PHASE4","title":"Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.","status":"NOT_YET_RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2024-03","conditions":"Corneal Epitheliopathy, Glaucoma, Corneal Disease","enrollment":25},{"nctId":"NCT05321251","phase":"PHASE2, PHASE3","title":"Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2022-06-01","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT06034366","phase":"NA","title":"the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-10-01","conditions":"Myopia","enrollment":150},{"nctId":"NCT01685398","phase":"PHASE3","title":"Topical Timolol for Superficial Infantile Hemangioma","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2012-09","conditions":"Hemangioma","enrollment":48},{"nctId":"NCT00816413","phase":"PHASE1, PHASE2","title":"Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2008-09","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT05713981","phase":"NA","title":"The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression","status":"COMPLETED","sponsor":"University of the Incarnate Word","startDate":"2023-03-01","conditions":"Meibomian Gland Dysfunction","enrollment":40},{"nctId":"NCT04290039","phase":"PHASE1","title":"Sublingual vs IV Atropine Bioavailability Study","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2020-01-04","conditions":"Toxic Effect of Organophosphate and Carbamate Insecticides","enrollment":15},{"nctId":"NCT04510428","phase":"PHASE2","title":"OSIG-eye Drops Treatment for Dry Eye Disease","status":"WITHDRAWN","sponsor":"University of Illinois at Chicago","startDate":"2023-05-15","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT05855486","phase":"NA","title":"PMCF Study to Evaluate Performance and Safety of \"LUXIDROPIN BABY & JUNIOR\"","status":"COMPLETED","sponsor":"C.O.C. Farmaceutici S.r.l.","startDate":"2022-10-12","conditions":"Ocular Discharge","enrollment":32},{"nctId":"NCT05165082","phase":"NA","title":"The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study","status":"COMPLETED","sponsor":"Taipei Medical University WanFang Hospital","startDate":"2021-12-21","conditions":"Paronychia, Epidermal Growth Factor Receptor Inhibitor","enrollment":8},{"nctId":"NCT04831047","phase":"PHASE4","title":"The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance","status":"COMPLETED","sponsor":"University of Miami","startDate":"2021-06-08","conditions":"Ptosis, Eyelid, Conjunctiva Inflamed, Eye Manifestations","enrollment":114},{"nctId":"NCT02978183","phase":"PHASE2","title":"Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Noveome Biotherapeutics, formerly Stemnion","startDate":"2016-12","conditions":"Allergic Conjunctivitis","enrollment":70},{"nctId":"NCT04938908","phase":"PHASE2","title":"Probiotic in Dry Eye Syndromes","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2021-07-01","conditions":"Dry Eye Syndrome","enrollment":40},{"nctId":"NCT05784519","phase":"EARLY_PHASE1","title":"Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease","status":"UNKNOWN","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2023-06-01","conditions":"Mesenchymal Stem Cell, Dry Eye Syndromes","enrollment":10},{"nctId":"NCT05771194","phase":"PHASE4","title":"Analysis of Postoperative Ocular Surface Changes and Intervention Effect After PPV in MGD Dry Eye Patients","status":"COMPLETED","sponsor":"Tianjin Medical University Eye Hospital","startDate":"2021-02-01","conditions":"Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid","enrollment":40},{"nctId":"NCT05320172","phase":"PHASE3","title":"Platelet Rich Plasma in Corneal Surface Diseases","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-06","conditions":"Persistent Corneal Epithelial Defects, Dry Eye","enrollment":70},{"nctId":"NCT05372991","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop","status":"COMPLETED","sponsor":"Cloudbreak Therapeutics, LLC","startDate":"2022-07-20","conditions":"Myopia, Progressive","enrollment":84},{"nctId":"NCT05677945","phase":"NA","title":"3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03","conditions":"Necrotic Primary Molars","enrollment":24},{"nctId":"NCT01375582","phase":"EARLY_PHASE1","title":"Objective Evaluation of Ocular Surface Lubricants in Two Environments","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2011-06","conditions":"Dry Eye","enrollment":20},{"nctId":"NCT05255016","phase":"PHASE2, PHASE3","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","status":"UNKNOWN","sponsor":"Peschke GmbH","startDate":"2022-03-14","conditions":"Keratitis, Corneal Ulcer","enrollment":488},{"nctId":"NCT05066698","phase":"PHASE2","title":"ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects","status":"TERMINATED","sponsor":"Noveome Biotherapeutics, formerly Stemnion","startDate":"2022-04-27","conditions":"Persistent Corneal Epithelial Defect","enrollment":8},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":"Near Vision","enrollment":75},{"nctId":"NCT05314621","phase":"PHASE4","title":"A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Andover Research Eye Institute","startDate":"2021-12-31","conditions":"Allergic Conjunctivitis","enrollment":61},{"nctId":"NCT05515471","phase":"PHASE3","title":"Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-02-04","conditions":"Treatment of Dry Eye Disease With Meibomian Gland Dysfunction","enrollment":312},{"nctId":"NCT03785340","phase":"PHASE3","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)","status":"COMPLETED","sponsor":"Ocugen","startDate":"2018-12-03","conditions":"Dry Eye","enrollment":252},{"nctId":"NCT03591874","phase":"PHASE3","title":"Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease","status":"TERMINATED","sponsor":"Ocugen","startDate":"2018-12-23","conditions":"Graft Versus Host Disease, Ocular Surface Disease, oGVHD","enrollment":59},{"nctId":"NCT05350384","phase":"","title":"An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy","status":"COMPLETED","sponsor":"University of Catania","startDate":"2021-06-18","conditions":"Purtscher Retinopathy, Pancreatic Cancer","enrollment":1},{"nctId":"NCT04883931","phase":"NA","title":"Mother Milk as a Eye Drop & Premature Retinopathy","status":"COMPLETED","sponsor":"Baskent University","startDate":"2021-05-06","conditions":"Retinopathy of Prematurity","enrollment":101},{"nctId":"NCT05268718","phase":"EARLY_PHASE1","title":"Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-08-01","conditions":"Keratitis, Ulcerative, Antibiotic Resistance, Microbial, Photothermal Therapy","enrollment":20},{"nctId":"NCT05145959","phase":"NA","title":"Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis","status":"UNKNOWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-12-01","conditions":"Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease","enrollment":30},{"nctId":"NCT01738243","phase":"PHASE4","title":"Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2013-12","conditions":"Thyroid Eye Disease","enrollment":2},{"nctId":"NCT03782701","phase":"PHASE4","title":"The Effect of Lumify™ Eyedrops on Eyelid Position","status":"COMPLETED","sponsor":"University of Miami","startDate":"2019-06-18","conditions":"Eyelid Droop","enrollment":43},{"nctId":"NCT04883996","phase":"PHASE1, PHASE2","title":"A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia","status":"UNKNOWN","sponsor":"Canyon City Eyecare","startDate":"2020-12-01","conditions":"Hyperopia, Myopia","enrollment":60},{"nctId":"NCT04877210","phase":"PHASE1","title":"Effects of Topical Insulin on Levels of Tear Inflammatory Mediators","status":"UNKNOWN","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2020-10-22","conditions":"Dry Eye","enrollment":60},{"nctId":"NCT01893359","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism","status":"TERMINATED","sponsor":"Glaukos Corporation","startDate":"2013-08","conditions":"Hyperopia, Hyperopic Astigmatism","enrollment":2},{"nctId":"NCT04063644","phase":"NA","title":"Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients","status":"COMPLETED","sponsor":"OPKO Health, Inc.","startDate":"2019-05-30","conditions":"Dry Eye Syndromes, Cataract","enrollment":100},{"nctId":"NCT02804191","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2016-07","conditions":"Conjunctivochalasis","enrollment":62},{"nctId":"NCT04087733","phase":"PHASE4","title":"Effectiveness of Liposomial Ozonized-Oil for Cataract Surgery","status":"COMPLETED","sponsor":"University of Molise","startDate":"2019-10-01","conditions":"Ocular Infections","enrollment":200},{"nctId":"NCT02472223","phase":"NA","title":"Reducing Adenoviral Patient Infected Days","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-03-23","conditions":"Conjunctivitis, Adenoviral Conjunctivitis","enrollment":28},{"nctId":"NCT03862053","phase":"PHASE4","title":"Manuka Eye Droops for Treatment of Allergy","status":"WITHDRAWN","sponsor":"Toyos Clinic","startDate":"2020-01-01","conditions":"Allergic Conjunctivitis","enrollment":""},{"nctId":"NCT04125394","phase":"NA","title":"Efficacy and Tolerance of Hypertonic Sodium Chloride (NaCl 5%) Eye Drops Without Preservatives in Corneal Edema","status":"UNKNOWN","sponsor":"Tiedra Farmacéutica SL","startDate":"2021-02-03","conditions":"Corneal Edema","enrollment":30},{"nctId":"NCT04140422","phase":"NA","title":"Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea","status":"COMPLETED","sponsor":"University Eye Hospital, Freiburg","startDate":"2019-10-24","conditions":"Fuchs' Endothelial Dystrophy","enrollment":68},{"nctId":"NCT02344225","phase":"PHASE2","title":"Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"2015-01-01","conditions":"Retinopathy of Prematurity","enrollment":14},{"nctId":"NCT03992482","phase":"PHASE1, PHASE2","title":"IVIG-eye Drops Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Sandeep Jain, MD","startDate":"2019-05-01","conditions":"Dry Eye","enrollment":27},{"nctId":"NCT01614847","phase":"PHASE4","title":"Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears","status":"COMPLETED","sponsor":"Thomas O Salmon, OD, PhD","startDate":"2012-06","conditions":"Dry Eye","enrollment":8},{"nctId":"NCT03245853","phase":"PHASE4","title":"Epi-On Corneal Crosslinking for Keratoconus","status":"COMPLETED","sponsor":"Comprehensive EyeCare of Central Ohio","startDate":"2017-07-18","conditions":"Keratoconus, Keratoconus, Unstable","enrollment":20},{"nctId":"NCT02448043","phase":"NA","title":"Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-06-04","conditions":"Nail Growth Cessation, Intraocular Pressure","enrollment":45},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT04122300","phase":"PHASE3","title":"Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct","status":"COMPLETED","sponsor":"University of Bern","startDate":"2011-05-22","conditions":"Congenita Nasolacrimal Duct Obstruction, Preterm Neonates, Ocular Discharge","enrollment":84},{"nctId":"NCT03739255","phase":"NA","title":"Facilitation of Corneal Re-epithelialization After Photorefractive Keratectomy","status":"UNKNOWN","sponsor":"SynsLaser Kirurgi AS","startDate":"2020-03-01","conditions":"Corneal Erosion","enrollment":20},{"nctId":"NCT03161080","phase":"NA","title":"Effect of Single Instillation of Three Different Topical Lubricants on Tear Film Thickness in Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-02-09","conditions":"Dry Eye Syndromes","enrollment":60},{"nctId":"NCT01933464","phase":"PHASE1, PHASE2","title":"An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2013-08","conditions":"Papulopustular Rosacea","enrollment":10},{"nctId":"NCT00981435","phase":"PHASE4","title":"Steroids After Laser Trabeculoplasty for Glaucoma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Glaucoma","enrollment":97},{"nctId":"NCT03836664","phase":"PHASE2","title":"A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2017-02-27","conditions":"Migraine","enrollment":25},{"nctId":"NCT00633854","phase":"","title":"High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2008-02","conditions":"Posterior Vitreous Detachment","enrollment":30},{"nctId":"NCT03851172","phase":"PHASE2","title":"Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03-01","conditions":"Cataract, Miosis","enrollment":75},{"nctId":"NCT02417116","phase":"NA","title":"Tear Osmolarity Clinical Utility in Dry Eye Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2015-06","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT03025945","phase":"NA","title":"Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo","status":"COMPLETED","sponsor":"Intuor Technologies, Inc.","startDate":"2013-10","conditions":"Cystoid Macular Edema","enrollment":662},{"nctId":"NCT01541891","phase":"PHASE2","title":"Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2011-10","conditions":"Dry Eye Syndrome","enrollment":30},{"nctId":"NCT02470429","phase":"NA","title":"Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2015-07-17","conditions":"Dry Eye","enrollment":114},{"nctId":"NCT01733745","phase":"NA","title":"SYSTANE® Family - Meibomian Deficiency","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-02","conditions":"Dry Eye Syndrome","enrollment":26},{"nctId":"NCT01688726","phase":"NA","title":"Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2012-12","conditions":"Dry Eye Syndrome, Lipid Deficiency","enrollment":91},{"nctId":"NCT02483897","phase":"PHASE3","title":"Effect of Tetracaine on Pain Management and Corneal Healing in Patients With Acute Corneal Abrasion","status":"WITHDRAWN","sponsor":"Queen's University","startDate":"2015-06","conditions":"Corneal Abrasion","enrollment":""},{"nctId":"NCT03417453","phase":"NA","title":"Eye Drop Dispensers: Safety, Efficacy and Comfort.","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2019-04-01","conditions":"Glaucoma, Cataract, Healthy Subjects","enrollment":50},{"nctId":"NCT02810119","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis","status":"COMPLETED","sponsor":"Ocuwize LTD","startDate":"2016-11","conditions":"Conjunctivochalasis","enrollment":13}],"_emaApprovals":[],"_faersSignals":[{"count":5,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"EYE IRRITATION"},{"count":2,"reaction":"CONSTIPATION"},{"count":2,"reaction":"DISCOMFORT"},{"count":2,"reaction":"DIZZINESS"},{"count":2,"reaction":"DRUG ADMINISTERED AT INAPPROPRIATE SITE"},{"count":2,"reaction":"DRY EYE"},{"count":2,"reaction":"EYE PAIN"},{"count":2,"reaction":"FEELING ABNORMAL"},{"count":2,"reaction":"INJECTION SITE PAIN"}],"_approvalHistory":[],"publicationCount":33,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"saline eye drops.","genericName":"saline eye drops.","companyName":"Jiangsu HengRui Medicine Co., Ltd.","companyId":"jiangsu-hengrui-medicine-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline eye drops work by lubricating the eyes to help relieve dryness and irritation. Used for Dry eye syndrome, Eye irritation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}